Search results
Your search for Derma-S returned no results
Showing 1 to 15 of 18 results for dermal-s
Showing 1 to 15 of 18 results for dermal-s
NICE has developed a medtech innovation briefing (MIB) on EpiFix for chronic wounds .
Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy (IPG439)
Evidence-based recommendations on deep dermal injection of non absorbable gel polymer for HIV-related facial lipoatrophy. This involves injecting the gel polymer under the skin to restore the shape and volume of the areas where fat has been lost.
View recommendations for IPG439Show all sections
Sections for IPG439
NICE has developed a medtech innovation briefing (MIB) on Permacol for treating anal fistulae .
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment (MTG2)
Evidence-based recommendations on moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment.
Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)
NICE has developed a medtech innovation briefing (MIB) on the Woundchek Protease Status for assessing elevated protease status in chronic wounds .
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.
This quality standard covers preventing, assessing, diagnosing and managing skin cancer (melanoma and non-melanoma skin cancer). It describes high-quality care in priority areas for improvement.
View quality statements for QS130Show all sections
Sections for QS130
NICE has developed a Medtech Innovation Briefing (MIB) on the Versajet II hydrosurgery system
explanatory notes(if applicable) Current evidence on the efficacy of deep dermal injection of non-absorbable gel polymer (NAGP) for...
Fetoscopic prenatal repair for open neural tube defects in the fetus (IPG667)
Evidence-based recommendations on fetoscopic prenatal repair of open neural tube defects in the fetus. This involves keyhole surgery through the woman’s abdomen to close the gap in the baby’s spine.
View recommendations for IPG667Show all sections
Open prenatal repair for open neural tube defects in the fetus (IPG668)
Evidence-based recommendations on open prenatal repair of open neural tube defects in the fetus. This involves open surgery through the woman’s abdomen to close the gap in the baby’s spine.
View recommendations for IPG668Show all sections
This guideline covers needle and syringe programmes for people (including those under 16) who inject drugs. The main aim is to reduce the transmission of viruses and other infections caused by sharing injecting equipment, such as HIV, hepatitis B and C. In turn, this will reduce the prevalence of blood-borne viruses and bacterial infections, so benefiting wider society.
Ticagrelor for the treatment of acute coronary syndromes (TA236)
Evidence-based recommendations on ticagrelor (Brilique) for treating acute coronary syndromes in adults.
NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .